Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia
release_tzq53wijrzeo7mm24z22ghpism
by
C Crescioli,
P Ferruzzi,
A Caporali,
M Scaltriti,
S Bettuzzi,
R Mancina,
S Gelmini,
M Serio,
D Villari,
G. Vannelli,
E Colli,
L Adorini
(+1 others)
Archived Files and Locations
application/pdf
284.3 kB
file_nbkckjzjrbagxf2nvyuxlo4m3i
|
www.eje-online.org (web) web.archive.org (webarchive) |
application/pdf
305.6 kB
file_ab7csuy5djabfdrsmoglnefnpi
|
eje.bioscientifica.com (web) web.archive.org (webarchive) |
application/pdf
305.6 kB
file_onibfal2yfbhxirjcstmepc52m
|
eje.bioscientifica.com (web) web.archive.org (webarchive) |
access all versions, variants, and formats of this works (eg, pre-prints)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar